Acelrx Pharmaceuticals, Inc.
Doing business as A Development Stage Company
- UEI
- RS3UJNCL6YG1
- CAGE
- 5ZVQ4
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $0 |
| FY2023 | -$46 |
Contract vehicles
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Dsuvia sufentnail nanotabs and storage | Defense Health Agency | $935,237 | |
| Sufentanil nanotab development | Medical Command (Army) | $17,012,744 |
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sufentanilnano tab study | Department of the Army | $5,598,600 |
Quick answers
Is Acelrx Pharmaceuticals, Inc. registered in SAM.gov?
Acelrx Pharmaceuticals, Inc.'s SAM.gov registration expired on December 13, 2023.
Which contract vehicles does Acelrx Pharmaceuticals, Inc. hold?
Acelrx Pharmaceuticals, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Acelrx Pharmaceuticals, Inc.'s most recent federal award?
Acelrx Pharmaceuticals, Inc.'s most recent federal contract award is Dsuvia sufentnail nanotabs and storage (W81XWH20C0133), from Defense Health Agency, on September 20, 2020.
On GovTribe
See Acelrx Pharmaceuticals, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors